Hydroxychloroquine can be ruled out as a treatment for hospitalized COVID-19 patients — but the World Health Organization says it is aware of ongoing trials into its value as a preventative measure.
A decades-old malaria and rheumatoid arthritis drug, hydroxychloroquine has been at the center of political and scientific controversy.
On Wednesday, the WHO decided to halt its trials of the drug for novel coronavirus patients in the hospital, after evidence from its own work and others that it had no effect on reducing the mortality rate.
Hydroxychloroquine pills (AP Photo/John Locher)
But the UN health agency says non-WHO trials into whether it might be useful in guarding against the virus have not yet concluded.
“As far as the use of hydroxychloroquine for prophylaxis or prevention of COVID-19 — either before or after exposure — the last word is not yet out,” WHO chief scientist Soumya Swaminathan tells a virtual press conference.
Animal lovers, this one's for you
In 1935, Rabbi Max Shorenstein left Denmark to pursue his lifelong dream: building a zoo in Tel Aviv and teaching children to love animals. The Tel Aviv Zoo became one of the city’s greatest attractions, but envy, greed, and corruption drove Shorenstein from the paradise he created.
The film 'There Are No Lions in Tel Aviv' is available to screen November 19-26 for members of our reader support group, The Times of Israel Community. Join the Community todayto support our work and watch our DocuNation series of outstanding Israeli documentary films.
We’re really pleased that you’ve read X Times of Israel articles in the past month.
That’s why we started the Times of Israel - to provide discerning readers like you with must-read coverage of Israel and the Jewish world.
So now we have a request. Unlike other news outlets, we haven’t put up a paywall. But as the journalism we do is costly, we invite readers for whom The Times of Israel has become important to help support our work by joining The Times of Israel Community.
For as little as $6 a month you can help support our quality journalism while enjoying The Times of Israel AD-FREE, as well as accessing exclusive content available only to Times of Israel Community members.
Thank you, David Horovitz, Founding Editor of The Times of Israel